Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders
申请人:Majid Nadeem Tahir
公开号:US20050009859A1
公开(公告)日:2005-01-13
Compounds of the formula I
are suitable for producing pharmaceuticals for the prophylaxis and therapy of diseases whose course involves an increased activity of NIK.